drugset / Trial / NCT07239765

A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMD

NCT07239765 ↗

Phase 3 Completed 67 enrolled CSPC Ouyi Pharmaceutical Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

Amphotericin B Cholesteryl Sulfate Complex (ABCD) is a generic drug of amphotericin B colloidal dispersion. This study aimed to explore the safety and efficacy of ABCD in patients with invasive mold disease.

Timeline

Start
2021-07-09
Primary completion
2024-04-08
Completion
2024-04-29

Drugs

EvaluationDrugModalityDoseRoute
Subject ABCD Unknown 3 mg/kg Intravenous
Subject ABCD Unknown 4 mg/kg Intravenous